{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:24:43Z","timestamp":1791897883235,"version":"4.3.4"},"reference-count":61,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Perinatology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.clp.2019.02.001","type":"journal-article","created":{"date-parts":[[2019,4,19]],"date-time":"2019-04-19T15:51:08Z","timestamp":1555689068000},"page":"159-172","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Drugs for the Treatment and Prevention of Preterm Labor"],"prefix":"10.1016","volume":"46","author":[{"given":"Soha S.","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Ludmir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clp.2019.02.001_bib1","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ajog.2012.03.010","article-title":"Progesterone and preterm birth prevention: translating clinical trials data into clinical practice","volume":"206","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.clp.2019.02.001_bib2","author":"March of Dimes"},{"key":"10.1016\/j.clp.2019.02.001_bib3","series-title":"Creasy & Resnik\u2019s maternal-fetal medicine: principles and practice","first-page":"624","author":"Creasy","year":"2014"},{"key":"10.1016\/j.clp.2019.02.001_bib4","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1097\/AOG.0000000000001265","article-title":"Practice bulletin no. 159: management of preterm labor","volume":"127","year":"2016","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.clp.2019.02.001_bib5","doi-asserted-by":"crossref","first-page":"R1415","DOI":"10.1152\/ajpregu.2000.278.6.R1415","article-title":"Inhibition of cyclooxygenase-2 prevents inflammation-mediated preterm labor in the mouse","volume":"278","author":"Gross","year":"2000","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.clp.2019.02.001_bib6","first-page":"983","article-title":"In\u00a0vitro study of tocolytic effect of rofecoxib, a specific cyclo-oxygenase 2 inhibitor. Comparison and combination with other tocolytic agents","volume":"109","author":"Doret","year":"2002","journal-title":"BJOG"},{"key":"10.1016\/j.clp.2019.02.001_bib7","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/j.2042-7158.1998.tb06905.x","article-title":"Tocolytic effect of the cyclooxygenase-2 inhibitor, meloxicam: studies on uterine contractions in the rat","volume":"50","author":"Yousif","year":"1998","journal-title":"J\u00a0Pharm Pharmacol"},{"key":"10.1016\/j.clp.2019.02.001_bib8","first-page":"563","article-title":"Uterine relaxant effects of cyclooxygenase-2 inhibitors in\u00a0vitro","volume":"98","author":"Slattery","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.clp.2019.02.001_bib9","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0002-9378(00)70226-2","article-title":"Effective diminution of amniotic prostaglandin production by selective inhibitors of cyclooxygenase type 2","volume":"182","author":"Sadovsky","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.clp.2019.02.001_bib10","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/0002-9378(80)90629-8","article-title":"The inhibition of premature labor with indomethacin","volume":"136","author":"Niebyl","year":"1980","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.clp.2019.02.001_bib11","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/00006254-199307000-00026","article-title":"Prostaglandin synthetase inhibitors in pregnancy","volume":"48","author":"Van den Veyver","year":"1993","journal-title":"Obstet Gynecol Surv"},{"issue":"6","key":"10.1016\/j.clp.2019.02.001_bib12","article-title":"Cyclooxygenase (COX) inhibitors for treating preterm labour","author":"Reinebrant","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.clp.2019.02.001_bib13","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1515\/jpme.1984.12.1.25","article-title":"Further study of the inhibition of premature labor by indomethacin. Part II double-blind study","volume":"12","author":"Zuckerman","year":"1984","journal-title":"J\u00a0Perinat Med"},{"key":"10.1016\/j.clp.2019.02.001_bib14","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/S0002-9378(11)90763-7","article-title":"Effect of advancing gestational age on the frequency of fetal ductal constriction in association with maternal indomethacin use","volume":"168","author":"Moise","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.clp.2019.02.001_bib15","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1056\/NEJM198808113190602","article-title":"Indomethacin in the treatment of premature labor. Effects on the fetal ductus arteriosus","volume":"319","author":"Moise","year":"1988","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clp.2019.02.001_bib16","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0002-9378(97)70184-4","article-title":"The effect of indomethacin tocolysis on fetal ductus arteriosus constriction with advancing gestational age","volume":"177","author":"Vermillion","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.clp.2019.02.001_bib17","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1056\/NEJM199311253292202","article-title":"Neonatal complications after the administration of indomethacin for preterm labor","volume":"329","author":"Norton","year":"1993","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clp.2019.02.001_bib18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1479-828X.1998.tb02949.x","article-title":"Antenatal indomethacin: adverse fetal effects confirmed","volume":"38","author":"Souter","year":"1998","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.clp.2019.02.001_bib19","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0002-9378(13)70288-6","article-title":"Tocolysis with indomethacin increases the incidence of necrotizing enterocolitis in the low-birth-weight neonate","volume":"170","author":"Major","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.clp.2019.02.001_bib20","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/sj.jp.7211256","article-title":"Outcome of very low birth weight infants exposed to antenatal indomethacin for tocolysis","volume":"25","author":"Doyle","year":"2005","journal-title":"J\u00a0Perinatol"},{"key":"10.1016\/j.clp.2019.02.001_bib21","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1542\/peds.2011-0265","article-title":"The risk of necrotizing enterocolitis after indomethacin tocolysis","volume":"128","author":"Sood","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.clp.2019.02.001_bib22","doi-asserted-by":"crossref","first-page":"505.e1","DOI":"10.1016\/j.ajog.2014.10.1091","article-title":"Antenatal exposure to indomethacin increases the risk of severe intraventricular hemorrhage, necrotizing enterocolitis, and periventricular leukomalacia: a systematic review with meta-analysis","volume":"212","author":"Hammers","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.clp.2019.02.001_bib23","doi-asserted-by":"crossref","first-page":"41.e1","DOI":"10.1016\/j.ajog.2007.12.037","article-title":"Neurodevelopmental outcome of premature infants after exposure to antenatal indomethacin","volume":"199","author":"Amin","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.clp.2019.02.001_bib24","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1055\/s-2007-973782","article-title":"Growth and development until 18\u00a0months of children exposed to tocolytics indomethacin or nylidrin","volume":"27","author":"Salokorpi","year":"1996","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.clp.2019.02.001_bib25","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1515\/jpme.1996.24.4.405","article-title":"Neurodevelopmental outcome of infants exposed to indomethacin antenatally","volume":"24","author":"al-Alaiyan","year":"1996","journal-title":"J\u00a0Perinat Med"},{"key":"10.1016\/j.clp.2019.02.001_bib26","series-title":"Williams obstetrics","first-page":"823","author":"Gary","year":"2005"},{"key":"10.1016\/j.clp.2019.02.001_bib27","author":"US Food and Drug Administration"},{"issue":"2","key":"10.1016\/j.clp.2019.02.001_bib28","article-title":"Betamimetics for inhibiting preterm labour","author":"Neilson","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"5 Pt 2","key":"10.1016\/j.clp.2019.02.001_bib29","first-page":"869","article-title":"Tocolytics for preterm labor: a systematic review","volume":"94","author":"Gyetvai","year":"1999","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.clp.2019.02.001_bib30","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/0002-9378(85)90397-7","article-title":"Tocolytic and hemodynamic effects of nifedipine in the Ewe","volume":"151","author":"Golichowski","year":"1985","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.clp.2019.02.001_bib31","article-title":"Calcium channel blockers for inhibiting preterm labour and birth","author":"Flenady","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clp.2019.02.001_bib32","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1471-0528.2010.02794.x","article-title":"Maternal and fetal haemodynamic effects of nifedipine in normotensive pregnant women","volume":"118","author":"Cornette","year":"2011","journal-title":"BJOG"},{"key":"10.1016\/j.clp.2019.02.001_bib33","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/00003081-199538040-00006","article-title":"Calcium channel blockers","volume":"38","author":"Ray","year":"1995","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.clp.2019.02.001_bib34","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/uog.1770","article-title":"The short-term effect of nifedipine tocolysis on placental, fetal cerebral and atrioventricular Doppler waveforms","volume":"24","author":"Guclu","year":"2004","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.clp.2019.02.001_bib35","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/0002-9378(89)90915-0","article-title":"Doppler assessment of the fetal and uteroplacental circulation during nifedipine therapy for preterm labor","volume":"161","author":"Mari","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.clp.2019.02.001_bib36","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0020-7292(94)02217-8","article-title":"Magnesium and calcium concentration in the pregnant and non-pregnant myometrium","volume":"48","author":"Cunze","year":"1995","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.clp.2019.02.001_bib37","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1093\/humrep\/15.9.2018","article-title":"Permeability of fetal membranes to calcium and magnesium: possible role in preterm labour","volume":"15","author":"Lemancewicz","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/j.clp.2019.02.001_bib38","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/0002-9378(93)90147-B","article-title":"Magnesium sulfate inhibits oxytocin-induced calcium mobilization in human puerperal myometrial cells: possible involvement of intracellular free magnesium concentration","volume":"169","author":"Mizuki","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.clp.2019.02.001_bib39","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1097\/AOG.0b013e3181a71551","article-title":"In defense of magnesium sulfate","volume":"113","author":"Elliott","year":"2009","journal-title":"Obstet Gynecol"},{"issue":"12","key":"10.1016\/j.clp.2019.02.001_bib40","article-title":"Different treatment regimens of magnesium sulphate for tocolysis in women in preterm labour","author":"McNamara","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"10.1016\/j.clp.2019.02.001_bib41","article-title":"Magnesium sulphate for preventing preterm birth in threatened preterm labour","author":"Crowther","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.clp.2019.02.001_bib42","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1067\/mob.2000.107334","article-title":"A\u00a0prospective, randomized, controlled trial of high and low maintenance doses of magnesium sulfate for acute tocolysis","volume":"182","author":"Terrone","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.clp.2019.02.001_bib43","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/01.AOG.0000433994.46087.85","article-title":"Committee opinion no. 573: magnesium sulfate use in obstetrics","volume":"122","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.clp.2019.02.001_bib44","first-page":"611","article-title":"Magnesium tocolysis and neonatal bone abnormalities: a controlled study","volume":"78","author":"Holcomb","year":"1991","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.clp.2019.02.001_bib45","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1159\/000291864","article-title":"Effects of long-term maternal intravenous magnesium sulfate therapy on neonatal calcium metabolism and bone mineral content","volume":"43","author":"Schanler","year":"1997","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.clp.2019.02.001_bib46","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1159\/000291492","article-title":"Effect of magnesium sulfate treatment on neonatal bone abnormalities","volume":"44","author":"Matsuda","year":"1997","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.clp.2019.02.001_bib47","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1055\/s-2007-994312","article-title":"Treatment of preterm labor with the oxytocin antagonist atosiban","volume":"13","author":"Goodwin","year":"1996","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.clp.2019.02.001_bib48","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/0002-9378(94)90414-6","article-title":"Effect of oxytocin antagonists on the activation of human myometrium in\u00a0vitro: atosiban prevents oxytocin-induced desensitization","volume":"171","author":"Phaneuf","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.clp.2019.02.001_bib49","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1067\/mob.2000.95834","article-title":"An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescue","volume":"182","author":"Romero","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.clp.2019.02.001_bib50","first-page":"133","article-title":"Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. The Worldwide Atosiban versus Beta-agonists Study Group","volume":"108","year":"2001","journal-title":"BJOG"},{"issue":"6","key":"10.1016\/j.clp.2019.02.001_bib51","article-title":"Oxytocin receptor antagonists for inhibiting preterm labour","author":"Flenady","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clp.2019.02.001_bib52","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1016\/S0140-6736(16)00548-1","article-title":"Nifedipine versus atosiban for threatened preterm birth (APOSTEL III): a multicentre, randomised controlled trial","volume":"387","author":"van Vliet","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.clp.2019.02.001_bib53","doi-asserted-by":"crossref","first-page":"b744","DOI":"10.1136\/bmj.b744","article-title":"Adverse drug reactions to tocolytic treatment for preterm labour: prospective cohort study","volume":"338","author":"de Heus","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.clp.2019.02.001_bib54","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1177\/107155769800500202","article-title":"Role and regulation of nitric oxide in the uterus during pregnancy and parturition","volume":"5","author":"Yallampalli","year":"1998","journal-title":"J\u00a0Soc Gynecol Investig"},{"issue":"5","key":"10.1016\/j.clp.2019.02.001_bib55","article-title":"Nitric oxide donors for treating preterm labour","author":"Duckitt","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clp.2019.02.001_bib56","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0015-0282(16)48490-6","article-title":"Congenital malformations among\u00a0offspring exposed in utero to progestins, Olmsted County, Minnesota, 1936-1974","volume":"43","author":"Resseguie","year":"1985","journal-title":"Fertil Steril"},{"key":"10.1016\/j.clp.2019.02.001_bib57","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1067\/mob.2003.41","article-title":"Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study","volume":"188","author":"da Fonseca","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.clp.2019.02.001_bib58","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/uog.9017","article-title":"PREGNANT Trial. Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo- controlled trial","volume":"38","author":"Hassan","year":"2011","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.clp.2019.02.001_bib59","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(16)00350-0","article-title":"Vaginal progesterone prophylaxis for preterm birth (the OPPTIMUM study): a multicentre, randomised, double-blind trial","volume":"387","author":"Norman","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.clp.2019.02.001_bib60","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1056\/NEJMoa035140","article-title":"Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate","volume":"348","author":"Meis","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clp.2019.02.001_bib61","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/01.AOG.0000281348.51499.bc","article-title":"Follow-up of children exposed in utero to 17 alpha-hydroxyprogesterone caproate compared with placebo","volume":"110","author":"Northen","year":"2007","journal-title":"Obstet Gynecol"}],"container-title":["Clinics in Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095510819300089?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095510819300089?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T15:57:36Z","timestamp":1758815856000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0095510819300089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":61,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0095510819300089"],"URL":"https:\/\/doi.org\/10.1016\/j.clp.2019.02.001","relation":{},"ISSN":["0095-5108"],"issn-type":[{"value":"0095-5108","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drugs for the Treatment and Prevention of Preterm Labor","name":"articletitle","label":"Article Title"},{"value":"Clinics in Perinatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clp.2019.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}